BackAEON Biopharma Overview

AEON Biopharma Long Term Debt

Track AEON Biopharma's long-term debt ($2.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$2.51M
↓ 84.49% YoYΔ $-13.68M vs prior year quarter

Peer trimmed avg / median

Loading

AEON Biopharma Long Term Debt History

Loading

AEON Biopharma vs. peers: Long Term Debt Comparison

Loading

AEON Biopharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AEON Biopharma (AEON) FAQ

AEON Biopharma (AEON) currently reports a long-term debt of $2.5M as of June 2026. That compares with $16M in the prior-year period — down 84.5% year over year. Use the charts on this page to explore AEON Biopharma's long-term debt history and peer comparisons.

AEON Biopharma's long-term debt decreased from $16M to $2.5M — a 84.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AEON Biopharma reported $2.5M in long-term debt as of June 2026. That compares with $16M in the prior-year period — down 84.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $2.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AEON Biopharma, and consider following AEON for alerts when major investors trade the stock.